ARVEX CV COMP A

Hazard statements (CLP)

H317, H319

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause an allergic skin reaction. Causes serious eye irritation

Hazard pictograms

GHS07

Signal word

Warning

Contains

2,2'-ETHYLENEDIOXYDIETHYL DIMETHACRYLATE; METHACRYLIC ACID, MONOESTER WITH PROPANE-1,2-DIOL; REACTION MASS OF 2,2'-[(4- METHYLPHENYL)IMINO]BISETHANOL AND ETHANOL 2-[[2-(2- HYDROXYETHOXY)ETHYL](4-METHYLPHENYL)AMINO]-

Hazard statements

H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.

Precautionary statements

P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P272 - Contaminated work clothing should not be allowed out of the workplace. P280 - Wear protective clothing, eye protection, face protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in REACTION MASS OF 2,2'-[(4-METHYLPHENYL)IMINO]BISETHANOL AND ETHANOL accordance with Article 59(1) of REACH for having 2-[[2-(2-HYDROXYETHOXY)ETHYL](4-METHYLPHENYL)AMINO]- (N/A) endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. Causes serious eye irritation.